Virpax Pharmaceuticals, Inc. (VRPX)

Virpax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.51	9.14	19	36.84	0.05
Cash & Short-Term Investments	1.51	9.14	19	36.84	0.05
Cash Growth	-83.45%	-51.88%	-48.44%	67134.82%	31.92%
Prepaid Expenses	0.04	0.2	0.18	0.16	0.01
Other Current Assets	0	0.28	0.5	2.57	0
Total Current Assets	1.56	9.63	19.67	39.57	0.07
Long-Term Deferred Charges	-	-	-	-	0.39
Total Assets	1.56	9.63	19.67	39.57	0.47
Accounts Payable	0.04	0.02	0.04	0.02	0.02
Accrued Expenses	2.43	1.68	1.06	2.07	3.08
Current Portion of Long-Term Debt	-	-	-	-	0.54
Current Income Taxes Payable	-	-	-	-	0.01
Other Current Liabilities	-	6	2	-	-
Total Current Liabilities	2.47	7.69	3.09	2.09	3.66
Long-Term Debt	-	-	-	-	1.02
Total Liabilities	2.47	7.69	3.09	2.09	4.68
Common Stock	0	0	0	0	0
Additional Paid-In Capital	70.7	61.48	60.93	60.19	6.43
Retained Earnings	-71.61	-59.54	-44.35	-22.7	-10.65
Shareholders' Equity	-0.91	1.93	16.58	37.48	-4.22
Total Liabilities & Equity	1.56	9.63	19.67	39.57	0.47
Total Debt	-	-	-	-	1.57
Net Cash (Debt)	1.51	9.14	19	36.84	-1.51
Net Cash Growth	-83.45%	-51.88%	-48.44%	-	-
Net Cash Per Share	8.89	195.13	405.53	1379.38	-121.54
Filing Date Shares Outstanding	1.06	0.05	0.05	0.05	0.02
Total Common Shares Outstanding	0.6	0.05	0.05	0.05	0.01
Working Capital	-0.91	1.93	16.58	37.48	-3.59
Book Value Per Share	-1.53	41.29	353.82	799.93	-335.12
Tangible Book Value	-0.91	1.93	16.58	37.48	-4.22
Tangible Book Value Per Share	-1.53	41.29	353.82	799.93	-335.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.